Medical Communications

Bellicum Pharmaceuticals has snatched up Genentech’s Rick Fair as its new CEO and President. Fair moves to Bellicum from Genentech …

Researchers from the University of Calgary have found that medication used to treat gout could also lessen the side-effects experienced …

The Heads of State convened from across Africa to ratify the Addis Declaration on Immunization (ADI). The pledge commits to …

Kathleen Tregoning has been announced as Sanofi’s vice president of External Affairs and as a new member of the Executive …

MSD, known as Merck in North America, has taken a pre-emptive step in the drug pricing debate by releasing its …

Juno Therapeutics has hired Corsee D. Sanders as its executive vice president and head of development operations. She will step …

Verily, a life sciences company owned by Alphabet, Google’s umbrella company, has announced that it has received $800 million in …

2017 has kicked off with a bang – as Johnson & Johnson confirmed a $30 billion deal to takeover of …

We’re nearing the end of the first month of the year and acqusitions have begun to introduce themselves with bang, …

Originally published in the latest issue of Pharmafile, Deloitte’s life sciences director Lee Feander discusses the often-undervalued importance of distribution …

Celgene has shelled out $300 million upfront, with a potential further $475 million in milestone payments, for Delinia, an autoimmune …

New research has found that artificial intelligence repurposed by researchers at Stanford University to identify skin cancer in images has …

Barr Laboratories, a subsidiary of Teva Pharmaceuticals, has settled an antitrust class action for $225 million. The case relates to …

Richard Bungay has been named as the new chief financial officer (CFO) of Diurnal; he has succeeded former CFO Ian …

NICE has issued its Technology Appraisal Guidance (TAG) that has recommend Imbruvica (ibrutinib) for the treatment of chronic lymphocytic leukaemia …